Mon, September 16, 2024
[ 12:00 AM ] - WOPRAI
Tue, May 14, 2024
[ 12:00 AM ] - WOPRAI
Mon, April 29, 2024
Thu, April 18, 2024
[ 12:00 AM ] - WOPRAI
Fri, April 5, 2024
[ 12:00 AM ] - WOPRAI
Thu, March 14, 2024
Thu, February 8, 2024
[ 12:00 AM ] - WOPRAI
Fri, December 1, 2023
[ 12:00 AM ] - WOPRAI
Tue, October 10, 2023
[ 12:00 AM ] - WOPRAI
Mon, June 5, 2023
[ 12:00 AM ] - WOPRAI
Fri, April 28, 2023
[ 12:00 AM ] - WOPRAI
Tue, March 7, 2023
[ 12:00 AM ] - WOPRAI
Wed, October 26, 2022
[ 12:00 AM ] - WOPRAI
Thu, September 15, 2022
[ 12:00 AM ] - WOPRAI
Tue, August 23, 2022
Wed, August 3, 2022
[ 12:00 AM ] - WOPRAI
Wed, July 27, 2022
[ 12:00 AM ] - WOPRAI
Fri, May 27, 2022
Mon, May 2, 2022
[ 12:00 AM ] - WOPRAI
Tue, March 8, 2022
[ 12:00 AM ] - WOPRAI
Fri, December 10, 2021
[ 12:00 AM ] - WOPRAI
Fri, August 20, 2021
[ 12:00 AM ] - WOPRAI
Thu, March 19, 2020
Aydin Huseynov Upgraded (ACRV) to Strong Buy and Held Target at $16 on, Sep 16th, 2024
Aydin Huseynov of Ladenburg Thalmann, Upgraded "Acrivon Therapeutics, Inc." (ACRV) to Strong Buy and Held Target at $16 on, Sep 16th, 2024.
Aydin, nor any peers, have made any analyst calls on ACRV in the last 4 months.
Warning: Undefined array key "user_peer_history" in /tmp/a6c06072cf4de09d3b84c924bfa9ab126ebc2b66_0.file.analysis.tpl.php on line 30
Contributing Sources